| 英文摘要 |
The Human Biobank Management Act and the Human Subjects Research Act reflect a relationship between specialized laws and general laws. However, since the Human Biobank Management Act was enacted before the Human Subjects Research Act, it could not draw on the essential differences between biobank research and the general research for which the Human Subjects Research Act is designed to formulate adequate, coherent regulation. The impact of this background has resulted in a systematic deviation. The Act not only creates many questions and problems in interpretation and application, but also contains many provisions that conflict with the regulatory rationale of biobank research. This article seeks to find a systematic entry point—drawing on the insights from the United States Common Rule—to comprehensively review the Human Biobank Management Act and provide specific directions for future legal reforms. This article argues that the critical point distinguishing biobank research from general research is the feature of providing materials for future unspecified research. Based on that, this article puts forward the following two suggestions regarding the legislative structure for future legislative reform:Transition from separate legislation to combined legislation;Shift focus from biobank phenomenon-centered to key behavior-centered. |